By Eden Laikin
Dozens of survivors, family members and healthcare professionals joined with Nassau County Executive Edward P. Mangano at the Theodore Roosevelt Executive and Legislative Building yesterday, to recognize Ovarian Cancer Awareness Month.
American Cancer Society estimates 22,280 women will be diagnosed with ovarian cancer in the United States in 2015 and approximately 14,240 women will die from the disease. Ovarian cancer is the leading cause of death from gynecologic cancers in the United States.
Yesterday, surrounded by representatives from the local chapter of the National Ovarian Cancer Coalition (NOCC) and the Monter Cancer Center at Northwell Health, and ovarian cancer survivors, County Executive Mangano illuminated the dome of the Mineola building in teal, to commemorate the women who have been threatened by ovarian cancer and those who have lost their lives.
“This light represents a beacon of hope – we can fight the disease,” County Executive Mangano said. “Until we have a cure, our best weapons include: knowing the symptoms, early detection and timely treatment.”
“As we light the dome teal we think of all the people who are battling ovarian cancer, all who have survived and all we must do to beat this terrible disease,” he added. “Together we can and will make the critical difference and save lives.”
The NOCC’s Mission is to save lives by fighting tirelessly to prevent and cure ovarian cancer and to improve the quality of life for survivors. It provides information to assist the newly diagnosed patient, to provide hope to survivors, and to support caregivers. Ovarian cancer is difficult to detect, as the symptoms of ovarian cancer are often vague and subtle. There is no effective screening test for ovarian cancer but tests exist that can identify women who are at higher risk for the disease. Only 20 percent of cases are caught before the cancer has spread beyond the ovary to the pelvic region. Most patients are diagnosed at advanced stages, and less than 50 percent of women survive longer than five years after diagnosis.